12-Month Angiographic and Clinical Results of the ReZolve® Sirolimus-Eluting Bioresorbable Coronary Scaffold: The RESTORE trial

被引:0
|
作者
Abizaid, Alexandre
Brachmann, Johannes [1 ]
Costa, Jose D., Jr. [2 ]
Dudek, Dariusz [3 ]
Frey, Norbert [4 ]
Heigert, Matthias [5 ]
Lutz, Matthias [6 ]
Schmermund, Axel [7 ]
Anderson, Jeffrey [8 ]
机构
[1] Klinikum Coburg, Coburg, Germany
[2] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil
[3] Univ Hosp, Krakow, Poland
[4] Univ Med Ctr Schleswig Holstein, Kiel, Germany
[5] Klin Innere Med Kardiol & Internist Intens Med, Salburg, Austria
[6] Univ Klinikum Schleswig Holstein, Kiel, Germany
[7] Cardioangiol Ctr Bethanien, Frankfurt, Germany
[8] Reva Med, San Diego, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:B13 / B13
页数:1
相关论文
共 50 条
  • [21] Impact of chronic kidney disease on clinical and angiographic results following implantation of sirolimus-eluting coronary stents
    Kawamura Y.
    Morino Y.
    Nagaoka M.
    Matsukage T.
    Masuda N.
    Ikari Y.
    Cardiovascular Intervention and Therapeutics, 2011, 26 (1) : 18 - 25
  • [22] NOYA I: A Prospective Randomized Trial of the Biodegradable Polymer NOYA Sirolimus-Eluting Stent Compared with the Durable Polymer FIREBIRD 2 Sirolimus-Eluting Stent in Patients with Coronary Artery Disease: 9-Month Angiographic and 24-Month Clinical Results
    Xu, Bo
    Dou, Kefei
    Yang, Yuejin
    Lu, Shuzheng
    Wang, Lefeng
    Wang, Haichang
    Li, Zhanquan
    Wang, Lei
    Chen, YunDai
    Huo, Yong
    Kirtane, Ajay
    Gao, Run-Lin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (17) : B164 - B164
  • [23] A First-in-Man Study of the Bioheart Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease: Six-Month Clinical and Imaging Outcomes
    Wu, Yongjian
    Sun, Zhongwei
    Gao, Lijian
    Qiao, Shubin
    Liu, Haibo
    Hu, Fenghuan
    Guan, Changdong
    Xu, Bo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (18) : B7 - B7
  • [24] Predictors of clinical and angiographic restenosis, in the sirolimus-eluting bx VELOCITY stent trial
    Mauri, L
    Popma, JJ
    Fitzgerald, PJ
    Leon, MB
    Moses, JW
    Holmes, DR
    Kuntz, RE
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 35A - 35A
  • [25] INITIAL RESULTS OF THE FANTOM 1 TRIAL: A FIRST-IN-MAN EVALUATION OF A NOVEL, RADIOPAQUE SIROLIMUS-ELUTING BIORESORBABLE VASCULAR SCAFFOLD
    Costa, Jose de Ribamar
    Abizaid, Alexandre
    Chamie, Daniel
    Lansky, Alexandra
    Kochman, Janusz
    Koltowski, Lukasz
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 232 - 232
  • [26] Clinical and multimodality imaging results at 6 months of a bioresorbable sirolimus-eluting scaffold for patients with single de novo coronary artery lesions: the NeoVas first-in-man trial
    Zhang, Yao-Jun
    Wang, Xiao-Zeng
    Fu, Guosheng
    Jing, Quan-Min
    Wang, Geng
    Jin, Chong-Ying
    Xie, Li-Hua
    Cai, Jin-Zan
    Xu, Bo
    Han, Ya-Ling
    EUROINTERVENTION, 2016, 12 (10) : 1279 - 1287
  • [27] One-year clinical outcomes and multislice computed tomography angiographic results following implantation of the NeoVas bioresorbable sirolimus-eluting scaffold in patients with single de novo coronary artery lesions
    Wang, Xiao-Zeng
    Zhang, Yao-Jun
    Fu, Guo-Sheng
    Jing, Quan-Min
    Xu, Bo
    Han, Ya-Ling
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 91 : 617 - 622
  • [28] Three-year clinical outcomes of a sirolimus-eluting bioresorbable scaffold (XINSORB) and a metallic stent to treat coronary artery stenosis
    Wu, Yizhe
    Yao, Zhifeng
    Yin, Jiasheng
    Chen, Jiahui
    Qian, Juying
    Shen, Li
    Ge, Lei
    Ge, Junbo
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (22)
  • [29] A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold withEverolimus-Eluting Metallic Stents in Patients With Coronary Artery Disease: Two-year Clinical Outcomes
    Han, Yaling
    Fu, Guosheng
    Wang, Xiaozeng
    Xu, Kai
    Xu, Bo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B173 - B173
  • [30] First-in-Man Study of Dedicated Bifurcation Sirolimus-Eluting Stent: 12-Month Results of BiOSS LIM® Registry
    Gil, Robert J.
    Bil, Jacek
    Vassiliev, Dobrin
    Inigo Garcia, Luis A.
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2015, 28 (01) : 51 - 60